Luigi Bolondi

Medicine · Health Sciences

78h-index40.7kcitations517works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(208), Liver Disease Diagnosis and Treatment(187), Liver Disease and Transplantation(137), MicroRNA in disease regulation(67), Organ Transplantation Techniques and Outcomes(41)

Publications517 total

Supplementary Figure S2 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Figure S3 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Data from MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
2023Open Access
Supplementary Tables and Figure Legends from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Tables and Figure Legends from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Data from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Data from MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
2023Open Access
Supplementary Data from MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
2023Open Access
Supplementary Figure S1 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplemetary Figure S4 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Figure S3 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplemetary Figure S4 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Data from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Figure S2 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023Open Access
Supplementary Table 1 from Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
2023Open Access
Supplementary Table 5 from Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
2023Open Access
Supplementary Figure 1 from MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
2023Open Access
Supplementary Figure 2 from MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
2023Open Access
Supplementary Table 2 from MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
2023Open Access
Supplementary Table 4 from Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
2023Open Access
page 1 of 26Next →

Frequent Co-authors

Fabio Piscaglia(19), Rita Golfieri(10), Vincenzo Mazzaferro(7), Laura Gramantieri(7), Alessandro Cucchetti(6), Stefano Gaiani(6), Antonio Daniele Pinna(6), Jean‐Luc Raoul(5), Jordi Bruix(5), Tito Livraghi(5), Francesca Fornari(5), Gian Luca Grazi(5), Massimo Negrini(5), Gianni Zironi(5), Armando Santoro(4), Peter R. Galle(4), Riccardo Lencioni(4), Matteo Renzulli(4), Franco Trevisani(4), Matteo Cescon(4)